Markus ZETTL

Follow

Person

Vienna, AT

People

Patents Grantslast 30 patents

Information Patent Grant
Antibody molecules for cancer treatment
- Patent number 11,795,219
- Issue date Oct 24, 2023
- Boehringer Ingelheim International GmbH
- Markus Zettl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antagonizing CD73 antibody
- Patent number 11,312,785
- Issue date Apr 26, 2022
- Boehringer Ingelheim International GmbH
- Irmgard Maria Rita Hofmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules for cancer treatment
- Patent number 11,028,169
- Issue date Jun 8, 2021
- Boehringer Ingelheim International GmbH
- Markus Zettl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODY MOLECULES FOR CANCER TREATMENT
- Publication number 20240124581
- Publication date Apr 18, 2024
- Boehringer Ingelheim International GmbH
- Markus ZETTL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES FOR CANCER TREATMENT
- Publication number 20210095020
- Publication date Apr 1, 2021
- Boehringer Ingelheim International GmbH
- Markus ZETTL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antagonizing CD73 Antibody
- Publication number 20190352420
- Publication date Nov 21, 2019
- Boehringer Ingelheim International GmbH
- Irmgard Maria Rita HOFMANN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY MOLECULES FOR CANCER TREATMENT
- Publication number 20170334995
- Publication date Nov 23, 2017
- Boehringer Ingelheim International GmbH
- Markus ZETTL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE